Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
EBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Other Operating Expenses (2017 - 2025)

Lifecore Biomedical, Inc. \De\ has reported Other Operating Expenses over the past 12 years, most recently at -$1.1 million for Q2 2025.

  • Quarterly results put Other Operating Expenses at -$1.1 million for Q2 2025, up 54.54% from a year ago — trailing twelve months through May 2025 was $409000.0 (down 98.96% YoY), and the annual figure for FY2025 was $409000.0, down 98.96%.
  • Other Operating Expenses for Q2 2025 was -$1.1 million at Lifecore Biomedical, Inc. \De\, down from -$600000.0 in the prior quarter.
  • Over the last five years, Other Operating Expenses for LFCR hit a ceiling of $21.0 million in Q1 2024 and a floor of -$19.5 million in Q2 2021.
  • Median Other Operating Expenses over the past 5 years was $200000.0 (2023), compared with a mean of $2.0 million.
  • Biggest five-year swings in Other Operating Expenses: tumbled 733.09% in 2021 and later skyrocketed 350.0% in 2024.
  • Lifecore Biomedical, Inc. \De\'s Other Operating Expenses stood at -$19.5 million in 2021, then skyrocketed by 110.84% to $2.1 million in 2022, then skyrocketed by 881.97% to $20.7 million in 2023, then tumbled by 94.2% to $1.2 million in 2024, then plummeted by 190.92% to -$1.1 million in 2025.
  • The last three reported values for Other Operating Expenses were -$1.1 million (Q2 2025), -$600000.0 (Q1 2025), and $1.2 million (Q4 2024) per Business Quant data.